MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submited by kickingbird at Jun, 16, 2006 16:18 PM from Medical News Today
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the company´s live, attenuated vaccinetechnology. [click link for full article]
See Also:
Latest news in those days:
- USCDC: A(H5N1) Bird Flu Response Update November 18, 2024 2 days ago
- US: Avian influenza confirmed in backyard flock of birds in Hawaii 5 days ago
- GISAID: H5N1 Bird Flu Circulating in Dairy Cows and Poultry in the United States 6 days ago
- China: Samples from Mai Po Nature Reserve test positive for H5N1 virus in Hong Kong S.A.R 7 days ago
- Statement from the Public Health Agency of Canada: Update on Avian Influenza and Risk to Canadians 8 days ago
[Go Top] [Close Window]
